Biocardia, Inc.
Clinical trials sponsored by Biocardia, Inc., explained in plain language.
-
Could your own bone marrow cells ease stubborn chest pain?
Disease control OngoingThis study tests a treatment called CardiAMP, which uses a patient's own bone marrow cells to improve blood flow to the heart. It is for people with severe chest pain (angina) that does not get better with standard medicines or procedures. About 343 adults will be randomly assign…
Phase: NA • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated May 17, 2026 08:18 UTC
-
Stem cells aim to heal lungs after severe COVID-19
Disease control TerminatedThis study tested whether stem cells from healthy donors could help people recover from severe lung damage caused by COVID-19. It was designed for adults who had been on a ventilator but had since improved. The trial was withdrawn before enrolling any participants, so no results …
Phase: PHASE1 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Could stem cells repair damaged hearts? new trial investigates
Disease control OngoingThis study tests whether stem cells from donated bone marrow can help people with heart failure caused by a past heart attack. About 39 adults with moderate heart failure will receive the cells through a special catheter. The goal is to see if the treatment is safe and can improv…
Phase: PHASE1, PHASE2 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated May 04, 2026 16:23 UTC